Related content

Cognitive dysfunction and dementia in Parkinson’s disease

By Bosboom J. L. W.   Stoffers D.   Wolters E. Ch.  

Journal of Neural Transmission, Vol. 111, Iss. 10-11, 2004-10 ,pp. : 1303-1315

Springer Publishing Company

Access to resources Recommend Favorite

Effects of pallidal deep brain stimulation and levodopa treatment on reaction-time performance in Parkinson’s disease

By Schubert T.   Volkmann J.   Müller U.   Sturm V.   Voges J.   Freund H.-J.   Cramon D.  

Experimental Brain Research, Vol. 144, Iss. 1, 2002-05 ,pp. : 8-16

Springer Publishing Company

Access to resources Recommend Favorite

Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson’s disease

By Vaillancourt David E.  

Brain, Vol. 127, Iss. 3, 2004-03 ,pp. : 491-504

Oxford University Press

Access to resources Recommend Favorite

Cholinesterase Inhibitors Modulate Autonomic Function in Patients with Alzheimer’s Disease and Mixed Dementia

By  

Current Alzheimer Research, Vol. 10, Iss. 5, 2013-06 ,pp. : 476-481

Bentham Science Publishers

Access to resources Recommend Favorite

Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson’s disease and dementia with Lewy bodies

By Power John   Blumbergs Peter  

Acta Neuropathologica, Vol. 117, Iss. 1, 2009-01 ,pp. : 63-73

Springer Publishing Company

Access to resources Recommend Favorite